Showing results (1691-1700 of 1,853) with videos related to

Sort By:
Pageof 186
Journal of Gastrointestinal Cancer|April 10, 2023
Efficacy of Pembrolizumab Monotherapy in Japanese Patients with Advanced Gastric or Gastroesophageal Junction CancerKei Muro, Kohei Shitara, Kensei Yamaguchi, et al.
Journal of Extracellular Vesicles|March 26, 2026
Gut Commensal Klebsiella pneumoniae Extracellular Vesicles Shape a Liver Microenvironment Conducive to Gut-Liver Bacterial Translocation and Pro-Tumorigenic ProcessesShogo Tsubaki, Sho Nashimoto, Rika Tanaka, et al.
ESMO Open|February 8, 2021
BIG BANG study (EPOC1703): multicentre, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy with binimetinib, encorafenib and cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancerDaisuke Kotani, Hideaki Bando, Hiroya Taniguchi, et al.
Journal of Gastroenterology|May 2, 2019
Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2)Tadakazu Hisamatsu, Shingo Kato, Reiko Kunisaki, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|April 20, 2023
Impact of an artificial intelligence-aided endoscopic diagnosis system on improving endoscopy quality for trainees in colonoscopy: Prospective, randomized, multicenter studyDaisuke Yamaguchi, Ryo Shimoda, Koichi Miyahara, et al.
Journal of Gastroenterology and Hepatology|October 1, 2020
Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn's disease? Systematic review and meta-analysisMotoi Uchino, Hiroki Ikeuchi, Keisuke Hata, et al.
Frontiers in Immunology|April 5, 2018
Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161++TCR iVα7.2+ Mucosal-Associated Invariant T Cells in Chronic Hepatitis B Virus InfectionYean K Yong, Alireza Saeidi, Hong Y Tan, et al.
BMC Immunology|April 16, 2025
Incidence of severe adverse events in cancer patients after treatment with immune-checkpoint inhibitors during the COVID- 19 pandemicSakiko Kimura, Hiroo Katsuya, Chiho Nakashima, et al.
American Journal of Hematology|January 21, 2018
Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label studyCarlo Gambacorti-Passerini, Sergey Orlov, Li Zhang, et al.
Scientific Reports|March 31, 2022
A novel renal perivascular mesenchymal cell subset gives rise to fibroblasts distinct from classic myofibroblastsShun Minatoguchi, Shoji Saito, Kazuhiro Furuhashi, et al.
Pageof 186